Genomic Valley Biotech Limited

Equities

GVBL6

INE574D01010

Market Closed - Bombay S.E. Other stock markets 03:30:57 04/07/2024 pm IST			5-day change	1st Jan Change
50.07 ^INR	-4.99%		-17.08%	+33.73%

09/05	Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
14/02	Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024	CI

Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2021

August 10, 2021 at 04:16 pm IST

Genomic Valley Biotech Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 169,600 compared to INR 277,600 a year ago. Net loss was INR 1.087 million compared to INR 1.354 million a year ago. Basic loss per share was INR 0.36 compared to INR 0.44 a year ago.

Latest news about Genomic Valley Biotech Limited

Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	09/05	CI
Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024	14/02	CI
Genomic Valley Biotech Limited Announces Change in Corporate Office Address	14/02	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Genomic Valley Biotech Limited Announces Resignation of Mrs. Jyoti Bansal as Non-Executive (Independent) Director of the Company Effective December 14, 2023	14/12	CI
Genomic Valley Biotech Limited Announces Resignation of Parul Agrawal as Non-Executive (Non-Independent) Director and Reconstitution of Committees	14/11	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11	CI
Genomic Valley Biotech Limited Announces Executive Changes	30/23/30	CI
Genomic Valley Biotech Limited Approves Shifting of Registered Office	30/23/30	CI
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Genomic Valley Biotech Limited Appoints Yogesh Agrawal as Chief Financial Officer	30/23/30	CI
Genomic Valley Biotech Limited Announces Executive Changes	30/23/30	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/23/29	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29/23/29	CI
Genomic Valley Biotech CFO Steps Down	03/23/03	MT
Genomic Valley Biotech Limited Announces CFO Changes	31/23/31	CI
Genomic Valley Biotech Limited Announces Change in Directorate	31/23/31	CI
Genomic Valley Biotech Limited Announces Resignation of Mr. Pritam as Company Secretary / Compliance Officer	02/23/02	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	10/23/10	CI
Genomic Valley Biotech Limited Announces Appointment of Mr. Pritam as Company Secretary and Compliance Officer	21/22/21	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	12/22/12	CI
Genomic Valley Biotech Turns to Net Profit in Fiscal Q1	20/22/20	MT
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	20/22/20	CI
Genomic Valley Biotech Limited Announces Resignation of Hanurnan Prasad as Company Secretary and Compliance Officer	23/22/23	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	29/22/29	CI